

How Kyzatrex Transforms Testosterone Therapy
Jan 7, 2025
Join Shalin Shah, CEO of Marius Pharmaceuticals and innovator behind Kyzatrex, an oral testosterone therapy that minimizes liver toxicity. He shares his journey from finance to health, illuminating how Kyzatrex's unique lymphatic absorption method offers safer alternatives for testosterone treatment. They tackle the side effects of traditional therapies, discuss patient education's role, and delve into the Testosterone Project's mission to improve access and understanding of hormone therapy. A groundbreaking conversation for anyone interested in the future of testosterone care.
Chapters
Books
Transcript
Episode notes
1 2 3 4 5 6
Intro
00:00 • 4min
The Evolution of Testosterone Therapy: Kyzatrex Unveiled
04:16 • 22min
Exploring New Horizons in Testosterone Therapy
25:58 • 5min
Understanding Testosterone Therapy
30:43 • 10min
Revolutionizing Access to Testosterone Therapy
40:28 • 2min
Exploring New Horizons in Testosterone Therapy
42:03 • 3min